Latest Hepacivac Stories
-Submission based on the largest Phase III program in genotype 1 (GT1) hepatitis C patients conducted to date(1) NORTH CHICAGO, Ill., April 22, 2014 /PRNewswire/ -- AbbVie (NYSE:
NEW YORK, March 25, 2014 /PRNewswire/ -- At the New York Viral Hepatitis Summit presented by the National Black Leadership Commission
Additional drug-drug interaction data for faldaprevir combined with commonly prescribed HIV medications also presented at CROI 2014 INGELHEIM, Germany and RIDGEFIELD, Conn., March
A hepatitis C vaccine is one step closer thanks to the efforts of scientists at The Scripps Research Institute, who have managed to discover unexpected structural features of a protein used by the virus to infect liver cells.
Infants who get hepatitis C from their mothers during childbirth may inherit a viral strain that replicates more quickly than strains found in non-pregnant hosts.
This discovery gives hope for a more effective and cheaper treatment strategy to millions worldwide suffering from chronic infectionsSingapore, Sept 21, 2013 - (ACN Newswire)
System Represents Major Advance in Studying Virus New York, NY (PRWEB) August 05, 2013 By differentiating monkey stem cells into liver cells and inducing
By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate in monkeys.
- totally perplexed and mixed up.